Free Trial

Elevation Oncology (ELEV) Earnings Date, Estimates & Call Transcripts

$2.56
-0.21 (-7.58%)
(As of 06/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(May. 2)
-$0.23 Missed By -$0.02
Consensus EPS
(May. 2)
-$0.21
Skip Charts & View Estimated and Actual Earnings Data

ELEV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELEV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elevation Oncology Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.23)($0.19)($0.21)
Q2 20243($0.26)($0.20)($0.22)
Q3 20243($0.22)($0.21)($0.21)
Q4 20243($0.23)($0.22)($0.23)
FY 202412($0.94)($0.82)($0.87)
Q1 20252($0.23)($0.15)($0.19)
Q2 20252($0.23)($0.14)($0.19)
Q3 20252($0.24)($0.16)($0.20)
Q4 20252($0.16)($0.16)($0.16)
FY 20258($0.86)($0.61)($0.74)

ELEV Earnings Date and Information

Elevation Oncology last released its earnings data on May 2nd, 2024. The reported ($0.23) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by $0.02. Elevation Oncology has generated ($1.04) earnings per share over the last year (($1.04) diluted earnings per share). Earnings for Elevation Oncology are expected to decrease in the coming year, from ($0.92) to ($0.95) per share. Elevation Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Elevation Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
5/2/2024Q1 2024($0.21)($0.23)($0.02)($0.23)--
3/6/2024Q4 2023($0.21)($0.19)+$0.02($0.19)--
11/2/2023Q3 2023($0.34)($0.25)+$0.09($0.25)--
8/3/2023Q2 2023($0.28)($0.37)($0.09)($0.37)--
5/15/2023Q1 2023($0.51)($0.50)+$0.01($0.28)--
3/9/2023Q4 2022($0.67)($4.09)($3.42)($4.09)--
11/3/2022Q3 2022($1.12)($1.67)($0.55)($1.67)--
8/4/2022Q2 2022($0.80)($0.86)($0.06)($0.86)--
5/5/2022Q1 2022($0.51)($0.74)($0.23)($0.74)--
3/3/2022Q4 2021($0.59)($0.41)+$0.18($0.41)--
11/11/2021Q3 2021($0.38)($0.53)($0.15)($0.53)--
8/12/2021Q2 2021($0.38)($4.84)($4.46)($4.84)--

Elevation Oncology Earnings - Frequently Asked Questions

When is Elevation Oncology's earnings date?

Elevation Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ELEV's earnings history.

Did Elevation Oncology beat their earnings estimates last quarter?

In the previous quarter, Elevation Oncology (NASDAQ:ELEV) missed the analysts' consensus estimate of ($0.21) by $0.02 with a reported earnings per share (EPS) of ($0.23). Learn more on analysts' earnings estimate vs. ELEV's actual earnings.

How much profit does Elevation Oncology generate each year?

Elevation Oncology (NASDAQ:ELEV) has a recorded net income of -$45.70 million. ELEV has generated -$1.04 earnings per share over the last four quarters.

What is Elevation Oncology's EPS forecast for next year?

Elevation Oncology's earnings are expected to decrease from ($0.92) per share to ($0.95) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ELEV) was last updated on 6/23/2024 by MarketBeat.com Staff

From Our Partners